88. Jahrestagung der Deutschen Gesellschaft für Kardiologie
Donnerstag, 21. April 2022 (Online-Channel 1) 11:00-12:30
Hotline
Late Breaking Clinical Trials I
Vorsitz: D. Dürschmied (Mannheim), A. Elsässer (Oldenburg)
11:00
(V656)
Plaque rupture and intact fibrous cap account for different outcomes in patients with acute coronary syndrome – results from the prospective OPTICO-ACS study – Sprecher
C. Seppelt (Berlin)
11:07
(V657)
Plaque rupture and intact fibrous cap account for different outcomes in patients with acute coronary syndrome – results from the prospective OPTICO-ACS study – Diskutant
D. G. Sedding (Halle (Saale))
11:11
Diskussion
11:15
(V658)
Rotational atherectomy vs. modified balloons prior to drug-eluting stent implantation in severely calcified coronary lesions: two-year results of the randomized PREPARE-CALC trial – Sprecher
G. Richardt (Bad Segeberg)
11:22
(V659)
Rotational atherectomy vs. modified balloons prior to drug-eluting stent implantation in severely calcified coronary lesions: two-year results of the randomized PREPARE-CALC trial – Diskutant
W. Rottbauer (Ulm)
11:26
Diskussion
11:30
(V660)
High inter-individual variability in LDL-cholesterol reductions after administration of the siRNA inclisiran – Sprecher
O. Weingärtner (Jena)
11:37
(V661)
High inter-individual variability in LDL-cholesterol reductions after administration of the siRNA inclisiran – Diskutant
A. M. Zeiher (Frankfurt am Main)
11:41
Diskussion
11:45
(V662)
Transseptal Mitral Valve Replacement, Early and Long Term Clinical and Hemodynamic Outcomes of the First 30 Consecutive Cases, HighLife Feasibility Studies in EU/Au/US – Sprecher
L. Schneider (Ulm)
11:52
(V663)
Transseptal Mitral Valve Replacement, Early and Long Term Clinical and Hemodynamic Outcomes of the First 30 Consecutive Cases, HighLife Feasibility Studies in EU/Au/US – Diskutant
T. Walther (Frankfurt am Main)
11:56
Diskussion
12:00
(V664)
“Jena auf Ziel – JaZ” - a prospective cohort study aiming to get all patients with ST-elevation myocardial infarction on EAS/ESC-LDL-C targets – Sprecherin
U. Makhmudova (Jena)
12:07
(V665)
“Jena auf Ziel – JaZ” - a prospective cohort study aiming to get all patients with ST-elevation myocardial infarction on EAS/ESC-LDL-C targets – Diskutantin
A. Bäßler (Regensburg)
12:11
Diskussion
12:15
(V666)
Primary and Extended 12-Month Device Closure Results of the AmplatzerTM AmuletTM IDE Trial of Left Atrial Appendage Occlusion – Sprecher
B. Schmidt (Frankfurt am Main)
12:22
(V667)
Primary and Extended 12-Month Device Closure Results of the AmplatzerTM AmuletTM IDE Trial of Left Atrial Appendage Occlusion – Diskutant
T. Lewalter (München)
12:26
Diskussion